Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| cell carcinoma of the prostate |
|
Renal type clear cell carcinoma of prostate Pal Dilip Kumar Though renal cell carcinoma is the classic example of clear cell carcinoma, only two cases metastasis in the prostate are reported. Prospective study of transitional cell carcinoma in the prostatic To prospectively evaluate the incidence of transitional cell carcinoma (TCC) in the prostatic urethra and prostate in the cystoprostatecto Prostatic adenocarcinoma coexist with transitional cell carcinoma transitional cell carcinoma in the prostate. Br J Urol. 1981;. 53:253-257. 2 Bates HR Jr. Transitional cell carcinoma of the prostate. J Small cell carcinoma of the prostate Prostate images Prostate diseases · Classification Google PubMed. Prostate. Small cell carcinoma of the prostate. Prostatic small cell carcinoma Small Cell Carcinoma of the Prostate: A Case Report and Discussion The importance of the recognition of small cell carcinoma of the prostate is emphasized because of the influence of small cell carcinoma on the prognosis. Serum calcitonin in small cell carcinoma of the prostate -- Sim et Small cell carcinoma (SCC) of the prostate is a rare and recently recognized subtype of prostate cancer. The neuroendocrine component of the prostate Adenoid cystic/basal cell carcinoma of the prostate strongly Adenoid cystic/basal cell carcinoma (ACBCC) is a rare neoplasm in the prostate. Definitive treatment is warranted, as among 19 patients previously reported Basal cell carcinoma of the prostate: current concepts basal cell carcinoma, adenoid cystic. carcinoma, prostate, prostate tumour, Basal cell carcinoma (BCC) of the. prostate is a rare variant, IngentaConnect Squamous cell carcinoma of the prostate Squamous cell carcinoma of the prostate is rare, accounting for 0.5â“1% of all prostatic cancers. It is highly aggressive and responds poorly to any mode of Oat-Cell Carcinoma of the Prostate One member of this group of atypical prostatic tumors is the oat-cell carcinoma, or small cell carcinoma (SCC) of the prostate. This variety of carcinoma Prostate Cancer with a Normal PSA: Small Cell Carcinoma of the Pure small cell carcinoma of the prostate is extremely rare. When it does occur, it is usually in concordance with prostatic adenocarcinoma. Adenoid Cystic/Basal Cell Carcinoma of the Prostate: Review and Adenoid Cystic/Basal Cell Carcinoma of the Prostate: Review and Update from Archives of Pathology & Laboratory Medicine in Health provided free by Find Postradiation therapy adenosquamous cell carcinoma of the prostate The objective of this study was to present two cases of adenosquamous cell carcinoma of the prostate following radiation therapy. Two patients with history Radiation Oncology | Full text | Squamous cell carcinoma of the Baker WJ, Carney JF: Squamous cell carcinoma of prostate. Sharma SK, Malik AK, Bapna BC: Squamous cell carcinoma of the prostate. Indian J Cancer 1980, Small cell carcinoma of the prostate: an immunohistochemical study. Small cell carcinoma of the prostate (SCPC) is morphologically similar to small cell carcinoma of the lung (SCLC) and maybe misinterpreted as Gleason The American Journal of Surgical Pathology - Abstract: Volume 32(1 Small cell carcinoma of prostate is rare, with the literature consisting of case reports and small series. The current work analyzes the morphology and Pleomorphic Giant Cell Carcinoma of the Prostate We report the clinical and pathologic features of 2 cases of pleomorphic giant cell carcinoma of the prostate. One case was found at autopsy in a The Journal of Urology : Primary Squamous cell Carcinoma of the Key Words: carcinoma, squamous cell; prostatic neoplasms; prostate; drug therapy, 1 Squamous cell carcinoma of the prostate appears to be much more Oncodiagnosis Panel: 1997 : Prostatic Carcinoma -- Lawton et al Small cell carcinoma of the prostate. Photomicrograph shows a tumor composed of cells with small hyperchromatic nuclei that have granular chromatic and |
| cell carcinoma of the prostate |
|
cancer prostate robotic surgery bill brooks prostate cancer anavar and prostate and hairloss cancer prostate recurrence |